Skip to main content
logo
Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
1.210
-0.010 (-0.82%)
Aug 12, 2026, 11:54 AM EDT - Market open

Biofrontera Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
43.241.7137.3234.0728.6724.1
Revenue Growth
13.72%11.75%9.54%18.82%18.98%27.86%
Gross Profit
33.3930.7418.7116.6313.4911.36
Operating Income
-11.12-11.35-17.21-22.68-18.58-25.2
Net Income
-16.73-10.54-17.76-20.13-0.64-37.71
Earnings Per Share
-0.97-1.04-3.22-13.02-0.61-85.63
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0001.4227.7624.55
Total Debt
7.726.164.925.41.350
Net Cash (Debt)
-7.72-6.16-4.92-3.9826.4124.55
Net Cash Growth
----7.60%203.78%
Net Cash Per Share
-0.71-0.61-0.89-2.5724.9955.73

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-9.31-13.36-10.27-24.9-16.2-26.72
Capital Expenditures
-0-0-0.01-0.01-0.04-0.01
Free Cash Flow
-9.32-13.36-10.28-24.9-16.24-26.73
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
77.29%73.71%50.14%48.80%47.04%47.13%
Operating Margin
-25.73%-27.21%-46.11%-66.56%-64.80%-104.57%
Pretax Margin
-27.65%-25.20%-47.53%-59.04%-2.12%-156.25%
Profit Margin
-38.71%-25.26%-47.58%-59.09%-2.23%-156.49%
FCF Margin
-21.57%-32.04%-27.54%-73.08%-56.63%-110.90%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.360.160.260.120.855.34